AVITA Shelf Registration Statement Filed with the SEC

• AVITA Medical filed a shelf registration statement with the SEC
• The shelf registration statement allows the company to offer and sell up to $200 million in securities
• The company currently has no plans to offer securities under the shelf registration statement

AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) has filed a shelf registration statement on Form S-3 with the United States Securities and Exchange Commission (SEC). The shelf registration statement allows the company to offer and sell from time to time, in one or more offerings, up to $200,000,000 in the aggregate of common stock, preferred stock, warrants, or units. Filing a shelf registration statement is common practice for public companies in the United States registered with the SEC, as it allows them to access the capital markets more efficiently when needed. AVITA Medical first filed a shelf registration statement in 2020, and this is the company's second filing, as shelf registration statements expire after three years. The company currently has no plans to offer securities covered by the Shelf Registration Statement, and it is possible that no securities will be offered or sold pursuant to the Shelf Registration Statement. Any offering of the securities covered by the Shelf Registration Statement will be subject to all applicable ASX Listing Rules.